p53-based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study.
Ha CS, Michalek JE, Elledge R, Kelly KR, Ganapathy S, Su H, Jenkins CA, Argiris A, Swords R, Eng TY, Karnad A, Crownover RL, Swanson GP, Goros M, Pollock BH, Yuan ZM.
Ha CS, et al.
Mol Oncol. 2016 Jan;10(1):148-56. doi: 10.1016/j.molonc.2015.09.004. Epub 2015 Sep 18.
Mol Oncol. 2016.
PMID: 26440706
Free PMC article.